Ortin Laboratories Ltd.

View in App
19.79 +0.34 ▲1.8%

04 October 2023, 04:01:00 PM
Volume: 1,352

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ortinlabsindia.com
Market Cap 16.14 Cr.
Enterprise Value(EV) 22.01 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 0.46 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 43.04 Trailing Twelve Months Ending 2023-06
Industry PE 38.26 Trailing Twelve Months Ending 2023-06
Book Value / Share 13.38 Trailing Twelve Months Ending 2023-06
Price to Book Value 1.48 Calculated using Price: 19.85
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.81 Cr. 8,131,392 Shares
FaceValue 10
About Ortin Laboratories Ltd.
Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Ortin Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Ortin Laboratories Ltd. Performance

View details >>
1 Day
+1.75%
1 Week
+1.49%
1 Month
+0.20%
3 Month
-11.45%
6 Month
+8.80%
1 Year
-15.79%
2 Year
-25.60%
5 Year
+17.80%
10 Year
+50.38%

Ortin Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.55 4.04 3.65 2.16 2.86 5.21 -2.31 5.38 -3.57
Return on Capital Employed (%) 13.62 11.55 11.01 9.58 10.14 11.76 8.93 3.27 1.59
Return on Assets (%) 1.62 1.28 1.25 0.79 1.00 1.43 -0.51 1.37 -1.90

Ortin Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 22 22 23 23 24 25 24 11 11 11
Non Curr. Liab. 6 8 16 8 8 8 9 2 2 3
Curr. Liab. 45 37 27 31 42 72 84 8 8 7
Minority Int.
Equity & Liab. 73 68 66 62 74 105 117 21 21 21
Non Curr. Assets 26 24 35 23 21 23 24 15 15 15
Curr. Assets 47 44 31 38 52 82 92 6 6 7
Misc. Exp. not W/O
Total Assets 73 68 66 62 74 105 117 21 21 21

Ortin Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 67 60 63 67 80 168 197 8 8 5
Other Income 1 0 1 0 0 1 0 0 0 0
Total Income 68 61 64 67 80 168 198 8 8 5
Total Expenditure -61 -54 -57 -61 -74 -162 -192 -7 -8 -4
PBIDT 7 7 6 6 6 7 6 1 1 1
Interest -4 -4 -3 -3 -3 -3 -3 -1 -1 0
Depreciation -2 -2 -2 -2 -2 -2 -2 0 0 0
Taxation -1 0 -1 -1 -1 -1 1 0 0
Exceptional Items
PAT 1 1 1 1 1 1 -1 1 0 0
Adjusted EPS 1 1 0 0 0 1 0 1 0 0

Ortin Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -2 -2 -1 1 2 2 7 3 18 2
Cash Fr. Inv. -2 0 0 -1 -1 -1 -3 -3 0 0
Cash Fr. Finan. 5 1 2 0 -1 0 -3 -1 -10 0
Net Change 1 -1 1 0 0 1 0 -1 8 2
Cash & Cash Eqvt 2 1 2 2 -14 -13 -13 -14 -5 -4

Ortin Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 15.68 15.68 15.68 15.68 15.68 15.68 15.68 21.51 7.36
Public 84.32 84.32 84.32 84.32 84.32 84.32 84.32 78.49 92.64
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Ortin Laboratories Ltd. Announcements

View details >>
Sat, 30 Sep 2023
Closure of Trading Window
Closure of Trading Window
Sat, 30 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 36th AGM
Sat, 30 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizers Report

Ortin Laboratories Ltd. Technical Scans

View details >>
Tue, 03 Oct 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High

Ortin Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 273,992.06 1,121.75 -1.8%
Divi's Laboratories Ltd. 98,792.80 3,702.05 -0.5%
Cipla Ltd. 95,478.34 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. 91,061.15 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. 73,583.24 5,048.70 -1.4%
Mankind Pharma Ltd. 72,079.88 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. 63,636.20 1,865.70 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.48 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 66.87 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 30.69 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.28 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.06 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.25 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.53 1,865.70 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.72 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 7.53 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 3.92 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.71 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.73 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.89 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.68 1,865.70 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,865.70 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,865.70 -0.8%

Ortin Laboratories Ltd. FAQ's

What is Ortin Laboratories share price?
Can I buy Ortin Laboratories shares now?
What is the Market Cap of Ortin Laboratories?
What are the key metrics to analyse Ortin Laboratories?
What is the 52 Week High and Low of Ortin Laboratories?
What is the trend of Ortin Laboratories share price?